| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |